1. ABCG2 and CD200 define patients at high risk of relapse in ELN favorable subgroup of AML. (20th July 2017) Authors: Tiribelli, Mario; Geromin, Antonella; Cavallin, Margherita; Di Giusto, Sara; Simeone, Erica; Fanin, Renato; Damiani, Daniela Journal: European journal of haematology Issue: Volume 99:Number 3(2017) Page Start: 269 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. BCR:ABL1 levels at first month after TKI discontinuation predict subsequent maintenance of treatment‐free remission: A study from the "GRUPPO TRIVENETO LMC". (8th October 2022) Authors: Di Giusto, Sara; Toffoletti, Eleonora; Bonifacio, Massimiliano; Binotto, Gianni; Miggiano, Maria Cristina; Calistri, Elisabetta; Stulle, Manuela; Ermacora, Anna; Stella, Rossella; Scaffidi, Luigi; D'Amore, Fabio; Scotton, Giorgia; Griguolo, Davide; De Matteis, Giovanna; Bertorelle, Roberta; Kramp... Journal: Cancer medicine Issue: Volume 12:Number 3(2023) Page Start: 3180 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Optimal timing of molecular monitoring after tyrosine kinase inhibitor discontinuation in chronic myeloid leukemia. (13th December 2022) Authors: Tiribelli, Mario; Toffoletti, Eleonora; Di Giusto, Sara; Fanin, Renato; Damiani, Daniela Journal: European journal of haematology Issue: Volume 110:Number 3(2023) Page Start: 330 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗